Apria, Inc.
Period
FY 2021
Revenue
$1.15B
Net Income
$64.88M
Total Assets
$775.43M
Equity
$39.73M
Shares Out
35.74M
Op. Cash Flow
$212.00M
Business
Apria, Inc. is a former operating company in Home Health Care Services, incorporated in Delaware. Securities are no longer actively traded on a major U.S. exchange.
Auto-generated from company profile
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2021 2021-12-31 | FY 2020 2020-12-31 | FY 2019 2019-12-31 |
|---|---|---|---|---|
| TOTAL NET REVENUES | 1,145 | 1,109 | 1,089 | |
| Product and supply costs | 206 | 193 | 206 | |
| Patient equipment depreciation | 101 | 101 | 97 | |
| Home respiratory therapists costs | 16 | 17 | 20 | |
| Other | 18 | 17 | 18 | |
| TOTAL COST OF NET REVENUES | 341 | 328 | 341 | |
| Selling, distribution and administrative | 707 | 709 | 721 | |
| TOTAL COSTS AND EXPENSES | 1,048 | 1,038 | 1,061 | |
| OPERATING INCOME | 97 | 71 | 27 | |
| Interest expense and other | 12 | 6 | 5 | |
| Interest income and other | −254,000 | −498,000 | −1 | |
| Gain from derecognition of nonfinancial asset | −4 | — | — | |
| INCOME BEFORE INCOME TAXES | 90 | 65 | 24 | |
| Income tax expense | 24 | 19 | 8 | |
| Loss from equity method investment | 791,000 | — | — | |
| NET INCOME | 65 | 46 | 16 | |
| Weighted average shares outstanding - basic | 35 | — | — | |
| Weighted average shares outstanding - diluted | 38 | — | — | |
| Net income per common share - basic | 1.79 | — | — | |
| Net income per common share - diluted | 1.66 | — | — |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2021 2021-12-31 | FY 2020 2020-12-31 | FY 2019 2019-12-31 | FY 2018 2018-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 220 | 195 | — | — | |
| Accounts receivable | 82 | 75 | — | — | |
| Inventories | 9 | 7 | — | — | |
| Prepaid expenses and other current assets | 23 | 24 | — | — | |
| TOTAL CURRENT ASSETS | 333 | 301 | — | — | |
| NONCURRENT RESTRICTED CASH | 515,000 | — | — | — | |
| PATIENT EQUIPMENT, less accumulated depreciation of $366,126 and $356,888 as of December 31, 2021 and December 31, 2020, respectively | 222 | 224 | — | — | |
| PROPERTY, EQUIPMENT AND IMPROVEMENTS, NET | 21 | 25 | — | — | |
| INTANGIBLE ASSETS, NET | 72 | 61 | — | — | |
| OPERATING LEASE RIGHT-OF-USE ASSETS | 72 | 58 | — | — | |
| GOODWILL | 29 | — | — | — | |
| EQUITY METHOD INVESTMENT | 3 | — | — | — | |
| DEFERRED INCOME TAXES, NET | 4 | 18 | — | — | |
| NOTE RECEIVABLE, RELATED PARTY (Note 12) | 2 | — | — | — | |
| OTHER ASSETS | 17 | 17 | — | — | |
| TOTAL ASSETS | 775 | 705 | — | — | |
| Accounts payable | 133 | 117 | — | — | |
| Accrued payroll and related taxes and benefits | 52 | 56 | — | — | |
| Other accrued liabilities | 33 | 34 | — | — | |
| Deferred revenue | 28 | 26 | — | — | |
| Current portion of operating lease liabilities | 23 | 24 | — | — | |
| Current portion of long-term debt | 36 | 21 | — | — | |
| TOTAL CURRENT LIABILITIES | 307 | 277 | — | — | |
| LONG-TERM DEBT, less current portion | 341 | 376 | — | — | |
| OPERATING LEASE LIABILITIES, less current portion | 48 | 35 | — | — | |
| DEFERRED INCOME TAXES, NET | 7 | — | — | — | |
| OTHER NONCURRENT LIABILITIES | 32 | 43 | — | — | |
| TOTAL LIABILITIES | 736 | 731 | — | — | |
| COMMITMENTS AND CONTINGENCIES (Note 10) | — | — | — | — | |
| Preferred stock, $0.01 par value: 100,000,000 authorized; no shares issued as of December 31, 2021 and February 10, 2021 (Note 1) | — | — | — | — | |
| Common stock, $0.01 par value: 1,000,000,000 authorized; 35,521,594 and 35,210,915 shares issued and outstanding as of December 31, 2021 and February 10, 2021, respectively (Note 1) | 355,000 | — | — | — | |
| Additional paid-in capital | 955 | 954 | — | — | |
| Accumulated deficit | −916 | −980 | — | — | |
| TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | 40 | −26 | 135 | 285 | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | 775 | 705 | — | — |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2021 2021-12-31 | FY 2020 2020-12-31 | FY 2019 2019-12-31 |
|---|---|---|---|---|
| Depreciation | 113 | 115 | 111 | |
| Amortization of intangible assets | 2 | 600,000 | 600,000 | |
| Non-cash lease expense | 27 | 27 | 28 | |
| Deferred income taxes | 21 | 16 | 9 | |
| Stock-based compensation | 8 | 3 | 9 | |
| Amortization of deferred debt issuance costs | 1 | 1 | 1 | |
| Loss on sale and dispositions of patient equipment and other | 7 | 4 | 4 | |
| Loss from unconsolidated joint venture | 791,000 | — | — | |
| Accounts receivable | −7 | 9 | 13 | |
| Inventories | 356,000 | 169,000 | 315,000 | |
| Prepaid expenses and other assets | 3 | −11 | 2 | |
| Accounts payable | 17 | −3 | −15 | |
| Accrued payroll and related taxes and benefits | −3 | 7 | 8 | |
| Operating lease liabilities | −29 | −25 | −29 | |
| Income taxes payable | 59,000 | −240,000 | −1 | |
| Deferred revenue | 983,000 | 961,000 | −610,000 | |
| Legal reserve | 1 | −12 | — | |
| Accrued expenses | −13 | 17 | 6 | |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 212 | 197 | 162 | |
| Purchases of patient equipment and property, equipment and improvements | −119 | −109 | −114 | |
| Proceeds from sale of patient equipment and other | 17 | 17 | 22 | |
| Preferred distribution from equity method investment | 3 | — | — | |
| Issuance of note receivable, related party | −2 | — | — | |
| Cash paid for acquisitions, net of cash received | −43 | — | — | |
| NET CASH USED IN INVESTING ACTIVITIES | −144 | −92 | −93 | |
| Payments on asset financing | −15 | −23 | −31 | |
| Proceeds from revolving credit facility | — | — | 5 | |
| Disbursements to revolving credit facility | — | — | −5 | |
| Borrowings on debt | — | 260 | 150 | |
| Payments on debt | −21 | −9 | — | |
| Payments on deferred financing costs | — | −3 | −3 | |
| Payments of dividend | — | −210 | −175 | |
| Distribution payments | −589,000 | — | — | |
| Payments for tax withholdings from equity-based compensation activity | −6 | — | — | |
| NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES | −43 | 16 | −59 | |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | 25 | 121 | 10 | |
| Unpaid purchases | 51 | 55 | 60 | |
| Unpaid purchases, extended payment terms | 9 | 16 | 24 | |
| Non-cash contribution of software and other intellectual property | 9 | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is Apria, Inc.'s CIK number?
Apria, Inc.'s SEC CIK number is 0001735803 (1735803). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Apria, Inc.'s SEC filings?
All of Apria, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.